[go: up one dir, main page]

Coussens et al., 2011 - Google Patents

Immortalized chick embryo cell line adapted to serum-free growth conditions and capable of replicating human and reassortant H5N1 influenza strains for vaccine …

Coussens et al., 2011

View PDF
Document ID
7175645898936312534
Author
Coussens P
Smith K
Weber P
Colvin C
Publication year
Publication venue
Vaccine

External Links

Snippet

The current process of influenza vaccine production can take 6–9 months and is dependent on the availability of embryonated eggs. Additionally, this process selects for receptor- binding variants with reduced antigenicity and requires significant downstream production …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses negative-sense
    • C12N2760/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses negative-sense ssRNA Viruses negative-sense
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses negative-sense
    • C12N2760/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses negative-sense ssRNA Viruses negative-sense
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses negative-sense
    • C12N2760/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses negative-sense ssRNA Viruses negative-sense
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Similar Documents

Publication Publication Date Title
Schulze-Horsel et al. Infection dynamics and virus-induced apoptosis in cell culture-based influenza vaccine production—Flow cytometry and mathematical modeling
DE60017234T2 (en) vaccine production
Pau et al. The human cell line PER. C6 provides a new manufacturing system for the production of influenza vaccines
Le Ru et al. Scalable production of influenza virus in HEK-293 cells for efficient vaccine manufacturing
Bissinger et al. Semi-perfusion cultures of suspension MDCK cells enable high cell concentrations and efficient influenza A virus production
Lugovtsev et al. Heterogeneity of the MDCK cell line and its applicability for influenza virus research
Stevens et al. Receptor specificity of influenza A H3N2 viruses isolated in mammalian cells and embryonated chicken eggs
US7521220B2 (en) Production of vaccines
KR100999345B1 (en) Method of producing drug or diagnostic active ingredient in MCDC cell suspension culture
Lohr et al. A new MDCK suspension line cultivated in a fully defined medium in stirred-tank and wave bioreactor
Peschel et al. Comparison of influenza virus yields and apoptosis-induction in an adherent and a suspension MDCK cell line
Lee et al. Evaluation of chicken-origin (DF-1) and quail-origin (QT-6) fibroblast cell lines for replication of avian influenza viruses
Huang et al. Serum-free suspension culture of MDCK cells for production of influenza H1N1 vaccines
Van Wielink et al. Adaptation of a Madin–Darby canine kidney cell line to suspension growth in serum-free media and comparison of its ability to produce avian influenza virus to Vero and BHK21 cell lines
Isken et al. Productivity, apoptosis, and infection dynamics of influenza A/PR/8 strains and A/PR/8-based reassortants
Sreenivasan et al. Development and characterization of swine primary respiratory epithelial cells and their susceptibility to infection by four influenza virus types
Lombardo et al. Susceptibility of different cell lines to Avian and Swine Influenza viruses
Hebert et al. Rapid quantification of vesicular stomatitis virus in Vero cells using Laser Force Cytology
Abdoli et al. Comparison between MDCK and MDCK-SIAT1 cell lines as preferred host for cell culture-based influenza vaccine production
Schulze-Horsel et al. Flow cytometric monitoring of influenza A virus infection in MDCK cells during vaccine production
Shcherbik et al. Evaluation of A (H1N1) pdm09 LAIV vaccine candidates stability and replication efficiency in primary human nasal epithelial cells
Massin et al. Temperature sensitivity on growth and/or replication of H1N1, H1N2 and H3N2 influenza A viruses isolated from pigs and birds in mammalian cells
Coussens et al. Immortalized chick embryo cell line adapted to serum-free growth conditions and capable of replicating human and reassortant H5N1 influenza strains for vaccine production
Asaoka et al. Low growth ability of recent influenza clinical isolates in MDCK cells is due to their low receptor binding affinities
US7527961B2 (en) Production of vaccines